Abstract

Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.

Original languageEnglish
Pages (from-to)4295-4304
JournalTumor Biology
Volume37
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Hepatocellular Carcinoma
Neoplasms
glucose-regulated proteins
AMP-Activated Protein Kinases
Heterografts
Small Interfering RNA
Growth

Keywords

  • AKT
  • eNOS
  • GRP94
  • HCC
  • Proliferation

ASJC Scopus subject areas

  • Cancer Research

Cite this

Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma. / Huang, Chien Yu; Batzorig, Uyanga; Cheng, Wan Li; Huang, Ming Te; Chen, Wei Yu; Wei, Po Li; Chang, Yu Jia.

In: Tumor Biology, Vol. 37, No. 4, 01.04.2016, p. 4295-4304.

Research output: Contribution to journalArticle

@article{fd9075a683df4be180f0250bf27b95b0,
title = "Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.",
keywords = "AKT, eNOS, GRP94, HCC, Proliferation",
author = "Huang, {Chien Yu} and Uyanga Batzorig and Cheng, {Wan Li} and Huang, {Ming Te} and Chen, {Wei Yu} and Wei, {Po Li} and Chang, {Yu Jia}",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s13277-015-4254-9",
language = "English",
volume = "37",
pages = "4295--4304",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma

AU - Huang, Chien Yu

AU - Batzorig, Uyanga

AU - Cheng, Wan Li

AU - Huang, Ming Te

AU - Chen, Wei Yu

AU - Wei, Po Li

AU - Chang, Yu Jia

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.

AB - Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.

KW - AKT

KW - eNOS

KW - GRP94

KW - HCC

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=84944936811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944936811&partnerID=8YFLogxK

U2 - 10.1007/s13277-015-4254-9

DO - 10.1007/s13277-015-4254-9

M3 - Article

C2 - 26493996

AN - SCOPUS:84944936811

VL - 37

SP - 4295

EP - 4304

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 4

ER -